---
title: "Heart Failure Prediction from MIMIC‑IV Multimodal Data: XGBoost vs Transformer"
id: "medrxiv-0-prediction-of-heart-failure-based-on-multimodal-data-from-mimic-iv"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-0-prediction-of-heart-failure-based-on-multimodal-data-from-mimic-iv"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.17.26360588v1?rss=1"
published_at: "2026-08-18T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Heart Failure Prediction from MIMIC‑IV Multimodal Data: XGBoost vs Transformer
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-0-prediction-of-heart-failure-based-on-multimodal-data-from-mimic-iv
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.17.26360588v1?rss=1)
- **Published At:** 2026-08-18T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This preprint evaluates early prediction of **heart failure** (HF) using multimodal clinical data from the MIMIC‑IV database, noting HF affects over 64 million people worldwide. - The study compares a classical machine learning model (**XGBoost**) and a deep learning **Transformer**‑based bidirectional cross‑attention model on the same multimodal inputs. - Cohorts of HF and non‑HF patients were identified by ICD‑9/10 codes and supplemented with laboratory results, radiology, and discharge note evidence. - A 48‑hour prediction window was defined prior to the first clinical evidence of HF to simulate early detection. - Structured features were engineered from rolling‑window statistics and clinical thresholds; models were trained on combinations of modalities and evaluated in an ablation study. - Multimodal models outperformed single‑modality models for both architectures. The multimodal **XGBoost** model achieved the highest reported performance (F1 0.8773; **PR‑AUC** 0.9402). The multimodal **Transformer** achieved F1 0.8635 and PR‑AUC 0.9209. - Structured data contributed most to XGBoost (PR‑AUC 0.9163), while clinical notes were better captured by the Transformer (PR‑AUC 0.8220). - The authors developed an explainable dashboard that produces quantitative 48‑hour HF risk estimates from a small set of laboratory and medication features to support clinician decision making. - Authors report institutional waivers for ethical approval because the work is a secondary analysis of the de‑identified MIMIC‑IV dataset; the preprint has not been peer reviewed and should not guide clinical practice. - All data used are publicly available via PhysioNet subject to credentialing and a data use agreement; code/data links were provided by the authors in the preprint.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=9a4HICPjN4MH.vTd9jcH9CcjeAaPoZe73trys00fmeo-1787093922.8191946-1.2.1.1-OKHb48qqfpEMGyoZ6UzqrXSp8UYIqdJSSKzD6FdNnwbcpAf.ow4Of5SqF2SCq9JI) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.17.26360588v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Prediction of Heart Failure based on Multimodal Data from MIMIC-IV [ View ORCID Profile](http://orcid.org/0009-0000-8705-7728)Anna Lutz, [ View ORCID Profile](http://orcid.org/0000-0001-6404-0827)Fabio Hellmann, [ View ORCID Profile](http://orcid.org/0000-0002-2367-162X)Elisabeth Andre doi: https://doi.org/10.64898/2026.08.17.26360588 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Anna Lutz University of Augsburg * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Anna%2BLutz%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lutz%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAnna%2BLutz%2B) * [ORCID record for Anna Lutz](http://orcid.org/0009-0000-8705-7728 "Open in new tab") * For correspondence: annasofielutz@icloud.com Fabio Hellmann University of Augsburg * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Fabio%2BHellmann%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hellmann%20F&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AFabio%2BHellmann%2B) * [ORCID record for Fabio Hellmann](http://orcid.org/0000-0001-6404-0827 "Open in new tab") Elisabeth Andre University of Augsburg * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Elisabeth%2BAndre%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Andre%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AElisabeth%2BAndre%2B) * [ORCID record for Elisabeth Andre](http://orcid.org/0000-0002-2367-162X "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.17.26360588v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1280831/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.17.26360588v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1280831/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.17.26360588v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1280831/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.17.26360588v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1280831/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.17.26360588v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1280831/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Heart failure (HF) affects over 64 million people worldwide and remains a leading cause of cardiovascular mortality. Early identification of patients at risk is essential for timely treatment and to support hospital and primary care physicians. This study compares XGBoost and a Transformer- based bidirectional cross-attention model using multimodal data to assess whether deep learning (DL) approaches can outperform classical machine learning (ML) methods for early HF prediction. We identified HF and non-HF patients from the MIMIC-IV database using ICD-9/10 codes, supplemented by clinical evidence from laboratory results, radiology, and discharge notes. Furthermore, we defined a 48-hour prediction window prior to the first clinical evidence of HF. Structured features were engineered from rolling-window statistics and clinical thresholds. Both XGBoost and Transformer models were trained on multimodal data and compared through an ablation study. Finally, we developed a dashboard using a small set of laboratory and medication features to deliver a 48- hour HF risk estimate, aiding clinician diagnosis. Multimodal models outperformed single-modality models across both architectures. The multimodal XGBoost model achieved the highest performance (F1 of 0. 8773 and PR-AUC of 0.9402), while the multimodal Transformer achieved slightly lower performance (F1 0.8635, PR-AUC 0.9209). Structured data contributed most to XGBoost (PR-AUC of 0.9163), whereas clinical notes were better captured by the Transformer (PR- AUC of 0.8220). Explainable dashboards further enhance transparency and usability by delivering quantitative 48-hour risk estimates from minimal features. This demonstrates, in this setting, that traditional ML can outperform DL models such as Transformers on tabular-dominated, multimodal clinical prediction tasks while preserving interpretability, underscoring decision-support systems potential to aid timely diagnosis. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Institutional Review Boards of the Massachusetts Institute of Technology and Beth Israel Deaconess Medical Center waived ethical approval for this work, as it is a secondary analysis of a de-identified, publicly accessible database (MIMIC-IV) and does not contain identifiable patient data. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data utilized in the present work are available online at PhysioNet (https://physionet.org/content/mimiciv/3.1/ , https://doi.org/10.13026/kpb9-mt58 and for the note database https://doi.org/10.13026/1n74-ne17, https://physionet.org/content/mimic-iv-note/2.2/). Access to the MIMIC-IV dataset is restricted to credentialed users who have completed the required training in human subjects research and signed a data use agreement Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.17.26360588v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.05.15.26353325v2 "WITHDRAWN: Real-World Validation of Machine Learning Models for HIV Treatment Adherence Prediction and Care Gap Quantification: A Multi-Country Analysis of 192,732 Clinical Records")[Next ](https://www.medrxiv.org/content/10.64898/2026.05.15.26353326v2 "WITHDRAWN: Facility-Level Structural Drivers of HIV Treatment Outcomes: A Multi-Level Analysis of 27,288 Patients from a Nigerian HIV Programme and Implications for PEPFAR and Global Fund Programming") Posted August 18, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.17.26360588v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/18/2026.08.17.26360588.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.17.26360588v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/18/2026.08.17.26360588.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Prediction of Heart Failure based on Multimodal Data from MIMIC-IV Anna Lutz, Fabio Hellmann, Elisabeth Andre medRxiv 2026.08.17.26360588; doi: https://doi.org/10.64898/2026.08.17.26360588 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.17.26360588v1%26text%3DPrediction%2520of%2520Heart%2520Failure%2520based%2520on%2520Multimodal%2520Data%2520from%2520MIMIC-IV "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.17.26360588v1%26t%3DPrediction%2520of%2520Heart%2520Failure%2520based%2520on%2520Multimodal%2520Data%2520from%2520MIMIC-IV "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.17.26360588v1%26title%3DPrediction%2520of%2520Heart%2520Failure%2520based%2520on%2520Multimodal%2520Data%2520from%2520MIMIC-IV%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.17.26360588v1%26title%3DPrediction%2520of%2520Heart%2520Failure%2520based%2520on%2520Multimodal%2520Data%2520from%2520MIMIC-IV "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.17.26360588) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.08.17.26360588v1&count=horizontal&via=&text=Prediction%20of%20Heart%20Failure%20based%20on%20Multimodal%20Data%20from%20MIMIC-IV&counturl=www.medrxiv.org/content/10.64898/2026.08.17.26360588v1 "Tweet This") ## Subject Area * [Health Informatics ](https://www.medrxiv.org/collection/health-informatics) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (605) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (891) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (324) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4727) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (473) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (403) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (635) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1605) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15742) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1192) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6933) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (723) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1047) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4923) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1417) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1721) * [Hematology](https://www.medrxiv.org/collection/hematology) (572) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1320) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16204) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1152) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (657) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (150) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (714) * [Neurology](https://www.medrxiv.org/collection/neurology) (7112) * [Nursing](https://www.medrxiv.org/collection/nursing) (359) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1066) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1215) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (990) * [Oncology](https://www.medrxiv.org/collection/oncology) (3553) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1026) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (384) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (440) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (463) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (138) * [Pathology](https://www.medrxiv.org/collection/pathology) (701) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1763) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (729) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (754) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5783) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9627) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2359) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1418) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1232) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (631) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (759) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (571) * [Surgery](https://www.medrxiv.org/collection/surgery) (755) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (106) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (300) * [Urology](https://www.medrxiv.org/collection/urology) (283) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations for this paper._ Blog/Media Links medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Video medRxiv partners with conferences and institutions to display recordings of talks and seminars related to preprints. These are posted
## Related Clinical Research

- [Retinal changes on OCT may predict atrial fibrillation risk years before diagnosis](https://medichelpline.com/clinical-feed/medical-news-today-0-how-changes-in-the-eyes-may-help-spot-afib-risk-years-early.md)
- [Impact of Nighttime Light Exposure on Heart Health and Disease Risk](https://medichelpline.com/clinical-feed/medical-news-today-0-nighttime-light-exposure-may-alter-the-heart-and-increase-disease-risk.md)
- [Quadriceps Femoris Ultrasound as a Rule-Out Screening Tool for Malnutrition in Heart Failure Clini](https://medichelpline.com/clinical-feed/medrxiv-5-ultrasound-of-quadriceps-femoris-as-a-rule-out-tool-for-malnutrition-screening.md)
- [Guideline-directed Medical Therapy for Heart Failure in People with HIV: Prescription Intensity an](https://medichelpline.com/clinical-feed/pubmed-42720139.md) (DOI: 10.1080/25787489.2026.2728496)
- [Photovoice with Peer Facilitation Reveals Social Drivers of Transition Readiness for Youth Living](https://medichelpline.com/clinical-feed/medrxiv-15-peer-facilitation-as-a-methodological-condition-what-participatory-photovoice.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.